MedPath

A Two-week Crossover Evaluation of Two Hand Antiseptic Products on Skin Condition in Healthy Human Subjects

Phase 4
Completed
Conditions
Healthy
Interventions
Drug: Purell Surgical Scrub
Drug: Avagard
Registration Number
NCT00731042
Lead Sponsor
Solventum US LLC
Brief Summary

Evaluate the effect of two hand antiseptic products on hand skin conditions of healthy volunteers.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
33
Inclusion Criteria
  • Female age 25 - 55
  • Subject agrees not to use any hand wash products on their hands other than what has been provided in the study.
  • Subject agrees not to use any moisturizers or any skin products on their hands during the study
  • Subject agrees to use gloves to protect hands from activities such as dish washing
  • Subject is willing to sign the Informed Consent and HIPAA
  • Subject agrees to comply with the study requirement
Exclusion Criteria
  • Subject has a history of psoriasis, active dermatitis, skin reactions, cracked, irritated, broken skin, skin infection on their hands
  • Subject has scaly skin on hands based on Visual Scoring Scale at Day 1
  • Subject has a sensitivity or history of skin reactions to any study materials (eg, alcohol, chlorhexidine gluconate or zinc pyrithone or latex in the gloves)
  • Subject has been using moisturizing products or any products on their arms and hands within 5 days prior to participation in the study
  • Subject is pregnant
  • Study coordinator believes the subject is unsuitable for inclusion in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
PurellPurell Surgical ScrubPurell Surgical Scrub with Moisturizers
AvagardAvagard3M Avagard Surgical and healthcare Personnel Hand Antiseptic with Moisturizers
Primary Outcome Measures
NameTimeMethod
Change From Baseline in Skin Health, Visual Skin Score (VSS) at 14 DaysBaseline and 14 days

Observe VSS score at 14 days, and graded change of skin health from baseline using scale of 0 (normal) - 5 (very scaly).

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath